51st Annual Meeting AISF

(Mal)nutrition and liver disease - G. Marchesini Reggiani, Bologna
Stem/progenitor cell niche in liver pathophisiology - V. Cardinale, Rome
Who is the candidate for liver transplantation in 2018 (and beyond)? - P-A Clavien, Zurich (Switzerland) (in attesa di autorizzazione)
Access to medicines in liver disease: what have learned? - S. Vella, Rome
Obesity and liver cancer: gender influence? - E. Vanni, Turin
HCC, HCV, DAAs and gender impact - M. Gambato, Padua
Gender, waiting list, transplantation and outcome - P. Toniutto, Udine